Phytochemical Name : Kahweol

Properties Information
PhytoCAT-ID PhytoCAT-1085
Phytochemical name or plant extracts Kahweol
PMID 30205135
Literature evidence Kahweol treatment substantially reduced the levels of HER2 protein, mRNA, and transcriptional activity in SKBR3 cells.
IUPAC name (1S,4S,12S,13R,16R,17R)-17-(hydroxymethyl)-12-methyl-8-oxapentacyclo[14.2.1.01,13.04,12.05,9]nonadeca-5(9),6,10-trien-17-ol
Phytochemicals’ class or type of plant extracts Diterpenoid
Source of phytochemicals or plant Extracts Coffea arabica
Geographical availability Ethiopia, Kenya, Sudan
Plant parts Beans
Other cancers Breast cancer
Target gene or protein PEA3, AP-2, FASN, SREBP-1c, mTOR
Gene or Protein evidence Kahweol exerts its potent anticancer efficacy by the upregulation of polyomavirus enhancer activator 3 (PEA3) and downregulation of activator protein 2 (AP-2) to inhibit aberrantly activated HER2 signaling. Fatty acid synthase (FASN) expression and sterol regulatory element-binding protein-1c (SREBP-1c) activity were downregulated by kahweol. In addition, kahweol lowered the levels of phosphorylated Akt and its downstream targets mammalian target of rapamycin (mTOR) and cyclin D1.
Target pathways Kahweol preferentially inhibited cell proliferation and induced cell death through the induction of a caspase 3-dependent pathway in HER2-overexpression breast cancer cell lines.
IC50 NA
Potency Overall, this study suggests that kahweol could be a useful adjuvant therapeutic agent in the treatment of HER2-overexpressing breast cancer.
Cell line/ mice model SKBR-3
Additional information  Furthermore, we found that blocking Akt signaling through kahweol treatment significantly reduced FASN expression and subsequently suppressed cell proliferation in HER2-overexpressing cancer cells.
PubChem ID 114778
Additional PMIDs NA
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:747038-1
Safety NA